Chronic, recurrent Lymphocytic Leukemia
Also known as: Chronic lymphocytic leukaemia recurrent / Chronic, recurrent Lymphocytic leukaemia / Recurrent Chronic Lymphocytic Leukaemia (CLL) / Chronic Lymphocytic Leukemia Recurrent / Recurrent Chronic Lymphocytic Leukemia / Chronic lymphoid leukemia in relapse (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB06650 | Ofatumumab | An anti-CD20 antibody used for the treatment of chronic lymphocytic leukemia (CLL) in selected patients with certain treatment histories and responsiveness to anticancer medications. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB06650 | Ofatumumab | B-lymphocyte antigen CD20 | target |